Bronchiectasis pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D.
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D.


==Overview==
= Overview==
Bronchiectasis involves bronchi that are permanently [[dilated]]  inflamed, and easily collapsible. This results in airflow obstruction and impaired clearance of [[secretions]]  Cole's Cycle describes how infections and a defect in the host defense are factors for this disease. An immune response also plays a role in the pathogenesis, which involves [[neutrophils]], [[lymphocytes]], and [[macrophages]].
Bronchiectasis involves bronchi that are permanently [[dilated]]  inflamed, and easily collapsible. This results in airflow obstruction and impaired clearance of [[secretions]]  Cole's Cycle describes how infections and a defect in the host defense are factors for this disease. An immune response also plays a role in the pathogenesis.


==Pathophysiology<ref>{{cite journal |author=Morrissey BM |title=Pathogenesis of bronchiectasis |language=English |journal=Clin Chest Med|volume=28 |issue=2 |pages=289-96 |year=2007 |pmid=17467548 |doi=}}</ref>==
==Pathophysiology<ref>{{cite journal |author=Morrissey BM |title=Pathogenesis of bronchiectasis |language=English |journal=Clin Chest Med|volume=28 |issue=2 |pages=289-96 |year=2007 |pmid=17467548 |doi=}}</ref>==

Revision as of 12:59, 29 June 2015

Bronchiectasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bronchiectasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bronchiectasis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bronchiectasis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bronchiectasis pathophysiology

CDC on Bronchiectasis pathophysiology

Bronchiectasis pathophysiology in the news

Blogs on Bronchiectasis pathophysiology

Directions to Hospitals Treating Bronchiectasis

Risk calculators and risk factors for Bronchiectasis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.

Overview=

Bronchiectasis involves bronchi that are permanently dilated inflamed, and easily collapsible. This results in airflow obstruction and impaired clearance of secretions Cole's Cycle describes how infections and a defect in the host defense are factors for this disease. An immune response also plays a role in the pathogenesis.

Pathophysiology[1]

  • Dilation of the bronchial walls results in airflow obstruction and impaired clearance of secretions
  • The dilated areas interrupt normal air pressure of the bronchial tubes, causing sputum to pool inside the dilated areas instead of being pushed upward
  • The pooled sputum provides an environment favorable to the growth of infectious pathogens
  • The more infections that the lungs experience, the more damaged the alveoli in the lung become
  • With more damage to the lung tissue, the bronchial tubes become more inelastic and dilated
  • This creates a perpetual, destructive cycle
  • The biopsies indicate that the infiltrate contains neutrophils, T lymphocytes and macrophages
  • The sputum contains elastase, interleukin-8, tumor necrosis factor a (TNF-a), and prostanoids

Cole's Cycle[2]

  • Also known as Cole's "vicious cycle hypothesis"
  • The most widely known model of the development of bronchiectasis
  • Impaired muco-ciliary clearance due to genetic susceptibility causes environmental insult
  • Results in persistence of microbes in the sinobronchial tree
  • The microbial infection causes chronic inflammation
  • This results in tissue damage and impaired mucociliary motility
  • This leads to more infection with a cycle of inflammation causing lung damage
  • Two factors required for the development of this condition are persistent infection and a defect in host defense

Immune Response


References

  1. Morrissey BM (2007). "Pathogenesis of bronchiectasis". Clin Chest Med. 28 (2): 289–96. PMID 17467548.
  2. King PT (2009). "The pathophysiology of bronchiectasis". Int J Chron Obstruct Pulmon Dis. 4: 411–9. PMC 2793069. PMID 20037680.


Template:WikiDoc Sources